332 related articles for article (PubMed ID: 24237252)
1. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.
Aĝirbaşli MA; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
Artif Organs; 2014 Jan; 38(1):28-33. PubMed ID: 24237252
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E levels in pediatric patients undergoing cardiopulmonary bypass.
Aĝirbaşli M; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
Artif Organs; 2015 Jan; 39(1):28-33. PubMed ID: 25626577
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of perfusion modes on vital organ recovery and thyroid hormone homeostasis in pediatric patients undergoing cardiopulmonary bypass.
Akçevin A; Alkan-Bozkaya T; Qiu F; Undar A
Artif Organs; 2010 Nov; 34(11):879-84. PubMed ID: 21092030
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
Eisses MJ; Chandler WL
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
7. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass.
Chandler WL; Fitch JC; Wall MH; Verrier ED; Cochran RP; Soltow LO; Spiess D
Thromb Haemost; 1995 Nov; 74(5):1293-7. PubMed ID: 8607112
[TBL] [Abstract][Full Text] [Related]
8. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
9. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
10. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.
Devin JK; Blevins LS; Verity DK; Chen Q; Bloodworth JR; Covington J; Vaughan DE
J Clin Endocrinol Metab; 2007 Sep; 92(9):3633-9. PubMed ID: 17579195
[TBL] [Abstract][Full Text] [Related]
11. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
Chandler WL; Velan T
Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
[TBL] [Abstract][Full Text] [Related]
12. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
Hevey D; McGee HM; Fitzgerald D; Horgan JH
Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile versus nonpulsatile flow during cardiopulmonary bypass: microcirculatory and systemic effects.
O'Neil MP; Fleming JC; Badhwar A; Guo LR
Ann Thorac Surg; 2012 Dec; 94(6):2046-53. PubMed ID: 22835552
[TBL] [Abstract][Full Text] [Related]
14. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
15. Effects of pulsatile and nonpulsatile perfusion on cerebral regional oxygen saturation and endothelin-1 in tetralogy of fallot infants.
Zhao J; Yang J; Liu J; Li S; Yan J; Meng Y; Wang X; Long C
Artif Organs; 2011 Mar; 35(3):E54-8. PubMed ID: 21375545
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
18. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
19. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
20. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
